AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% – Tale of the Tape

Zacks
AVEO Pharmaceuticals, Inc. (AVEO) was a big mover last session, as the company saw its shares rise nearly 8% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $1.02 to $1.21 in the past one-month time frame, showed a pick-up yesterday at $1.10.

The company has seen 2 positive estimate revisions in the past one month, while its Zacks Consensus Estimate of a loss narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

AVEO Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other players in the healthcare industry include Illumina Inc. (ILMN), Gilead Sciences Inc. (GILD) and ANI Pharmaceuticals, Inc. (ANIP) all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply